Potential antagonism of tubulin-binding anticancer agents in combination therapies. [electronic resource]
Producer: 20050808Description: 2720-6 p. digitalISSN:- 1078-0432
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cell Adhesion -- drug effects
- Cell Line
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cisplatin -- administration & dosage
- Colchicine -- administration & dosage
- Cytoskeleton -- drug effects
- Docetaxel
- Dose-Response Relationship, Drug
- Doxorubicin -- administration & dosage
- Drug Interactions
- Endothelial Cells -- drug effects
- Female
- Humans
- Mice
- Mice, Inbred C57BL
- Mice, Nude
- Microscopy, Fluorescence
- Necrosis -- prevention & control
- Organophosphorus Compounds -- administration & dosage
- Paclitaxel -- administration & dosage
- Protein Binding
- Taxoids -- administration & dosage
- Tubulin -- metabolism
- Umbilical Veins -- cytology
- Vincristine -- administration & dosage
- Xenograft Model Antitumor Assays -- methods
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.